127 related articles for article (PubMed ID: 17146390)
1. Role of computed tomography imaging in predicting response of nasopharyngeal carcinoma to definitive radiation therapy.
Ma X; Lu JJ; Loh KS; Shakespeare TP; Thiagarajan A; Goh BC; Tan KS
Laryngoscope; 2006 Dec; 116(12):2162-5. PubMed ID: 17146390
[TBL] [Abstract][Full Text] [Related]
2. Post-radiation CT changes and recurrent nasopharyngeal carcinoma.
Luo DH; Zhou CW; Li EN; Wen BX
Chin Med J (Engl); 2008 May; 121(10):916-22. PubMed ID: 18706206
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of recurrent nodal disease after definitive radiation therapy for nasopharyngeal carcinoma: diagnostic value of fine-needle aspiration cytology and CT scan.
Toh ST; Yuen HW; Goh YH; Goh CH
Head Neck; 2007 Apr; 29(4):370-7. PubMed ID: 17123306
[TBL] [Abstract][Full Text] [Related]
5. Positron emission tomography-computed tomography before treatment is highly prognostic of distant metastasis in nasopharyngeal carcinoma patients after intensity-modulated radiotherapy treatment: a prospective study with long-term follow-up.
Xiao W; Xu A; Han F; Lin X; Lu L; Shen G; Huang S; Fan W; Deng X; Zhao C
Oral Oncol; 2015 Apr; 51(4):363-9. PubMed ID: 25655559
[TBL] [Abstract][Full Text] [Related]
6. Detection of local failures after management of nasopharyngeal carcinoma: a prospective, controlled trial.
Ragab SM; Erfan FA; Khalifa MA; Korayem EM; Tawfik HA
J Laryngol Otol; 2008 Nov; 122(11):1230-4. PubMed ID: 18371235
[TBL] [Abstract][Full Text] [Related]
7. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma.
Lu TX; Mai WY; Teh BS; Zhao C; Han F; Huang Y; Deng XW; Lu LX; Huang SM; Zeng ZF; Lin CG; Lu HH; Chiu JK; Carpenter LS; Grant WH; Woo SY; Cui NJ; Butler EB
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):682-7. PubMed ID: 14967420
[TBL] [Abstract][Full Text] [Related]
8. Tumor volume is not an independent prognostic factor in early-stage nasopharyngeal carcinoma treated by radiotherapy alone.
Chua DT; Sham JS; Leung LH; Tai KS; Au GK
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1437-44. PubMed ID: 15050321
[TBL] [Abstract][Full Text] [Related]
9. Staging and follow-up of nasopharyngeal carcinoma: magnetic resonance imaging versus computerized tomography.
Olmi P; Fallai C; Colagrande S; Giannardi G
Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):795-800. PubMed ID: 7790266
[TBL] [Abstract][Full Text] [Related]
10. Comparison of physical examination and fluorodeoxyglucose positron emission tomography/computed tomography 4-6 months after radiotherapy to assess residual head-and-neck cancer.
Zundel MT; Michel MA; Schultz CJ; Maheshwari M; Wong SJ; Campbell BH; Massey BL; Blumin J; Wilson JF; Wang D
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e825-32. PubMed ID: 21300450
[TBL] [Abstract][Full Text] [Related]
11. [Serial (18)F-FDG PET-CT imaging during radiotherapy for nasopharyngeal carcinoma: a prospective clinical study].
Lin Q; Yang RS; Sun L; Li YM; Wang LC; Dai MM; Luo ZM; Zhao L; Wu H
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):356-9. PubMed ID: 22883456
[TBL] [Abstract][Full Text] [Related]
12. The risk of second primary tumors in patients with nasopharyngeal carcinoma after definitive radiotherapy.
Kong L; Lu JJ; Hu C; Guo X; Wu Y; Zhang Y
Cancer; 2006 Sep; 107(6):1287-93. PubMed ID: 16909425
[TBL] [Abstract][Full Text] [Related]
13. A prospective study of p53 expression and its correlation with clinical response of radiotherapy in nasopharyngeal carcinoma.
Ho KY; Kuo WR; Chai CY; Tsai SM; Sheu SH; Wu SC; Juan KH
Laryngoscope; 2001 Jan; 111(1):131-6. PubMed ID: 11192881
[TBL] [Abstract][Full Text] [Related]
14. CT perfusion in predicting treatment response of nasopharyngeal carcinoma.
Tuntiyatorn L; Fusuwankaya E; Sawangsilpa T; Bhongmakapat T
J Med Assoc Thai; 2014 Mar; 97(3):333-41. PubMed ID: 25123014
[TBL] [Abstract][Full Text] [Related]
15. [The role of retropharyngeal lymph node metastasis in staging of nasopharyngeal carcinoma].
Tang LL; Liu LZ; Ma J; Zong JF; Huang Y; Lin AH; Lu TX; Cui NJ
Ai Zheng; 2006 Feb; 25(2):129-35. PubMed ID: 16480573
[TBL] [Abstract][Full Text] [Related]
16. Nasopharyngeal carcinoma: United Kingdom National Multidisciplinary Guidelines.
Simo R; Robinson M; Lei M; Sibtain A; Hickey S
J Laryngol Otol; 2016 May; 130(S2):S97-S103. PubMed ID: 27841121
[TBL] [Abstract][Full Text] [Related]
17. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience.
Kam MK; Teo PM; Chau RM; Cheung KY; Choi PH; Kwan WH; Leung SF; Zee B; Chan AT
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1440-50. PubMed ID: 15590175
[TBL] [Abstract][Full Text] [Related]
18. [Value of FDG PET-CT associated with pathology in diagnosing residual tumor in patients with nasopharyngeal carcinoma after radiotherapy].
Chen L; Zhang N; Wang Y; Xian W; Hu W; Wei G
Zhonghua Zhong Liu Za Zhi; 2015 Mar; 37(3):213-5. PubMed ID: 25975792
[TBL] [Abstract][Full Text] [Related]
19. Treatment outcome after radiotherapy alone for patients with Stage I-II nasopharyngeal carcinoma.
Chua DT; Sham JS; Kwong DL; Au GK
Cancer; 2003 Jul; 98(1):74-80. PubMed ID: 12833458
[TBL] [Abstract][Full Text] [Related]
20. [Preliminary study on the value of 99Tc(m)-HL91 imaging in predicting sensitivity to radiotherapy in patients with nasopharyngeal carcinoma].
Liu S; Xue Y; Zhang H; Liang JG; Lu XP; Liu XG; Chen SX; Jing NY
Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):369-72. PubMed ID: 17892134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
